Skip to main content
. 2020 Jul 2;11:2042018820937896. doi: 10.1177/2042018820937896

Table 2.

Levothyroxine prescriptions divided by the percentage of each dose that was prescribed on an annual basis, and subdivided by whether a diagnosis of hypothyroidism was documented or not.

LT4 dose (µg) Percentage of each LT4 dose prescribed per year
2008
2009
2010
2011
2012
2013
2014
2015
2016
No hypo Hypo No hypo Hypo No hypo Hypo No hypo Hypo No hypo Hypo No hypo Hypo No hypo Hypo No hypo Hypo No hypo Hypo
25 6.8 5.7 7.3 5.8 7.3 6.2 8.1 7.5 8.1 8.1 9.0 8.4 8.5 8.5 8.5 8.5 8.2 8.4
50 15.6 14.2 15.1 14.1 15.0 14.9 15.4 15.7 16.0 16.8 16.7 16.9 15.7 16.8 15.6 17.1 15.5 16.9
75 14.8 14.5 14.0 13.4 14.6 13.8 15.0 13.8 14.7 14.5 15.2 14.5 15.9 14.8 15.4 15.1 15.7 15.4
88 7.7 6.3 7.2 7.3 8.2 7.2 8.2 7.8 9.2 8.0 9.1 8.3 9.1 8.5 9.4 8.4 9.7 9.0
100 16.2 15.6 15.8 15.5 15.3 14.1 16.2 13.6 14.9 13.7 14.7 13.8 14.9 14.1 14.7 14.1 15.1 14.0
112 8.3 7.8 8.7 8.3 8.8 8.4 9.0 8.3 8.1 7.9 8.2 8.1 8.7 7.9 8.8 7.7 9.0 8.3
125 10.1 11.2 11.0 10.8 11.1 10.3 9.1 10.3 10.0 9.9 9.3 9.6 9.4 9.4 9.1 9.3 9.0 9.0
137 3.6 5.0 4.3 5.5 4.4 5.4 4.4 5.1 4.7 4.7 4.2 4.5 4.2 4.7 4.8 4.8 4.7 4.6
150 8.7 9.0 8.1 8.9 7.2 9.1 7.3 8.1 7.0 7.5 6.7 7.1 6.8 6.8 6.4 7.0 6.4 6.7
175 4.1 5.5 4.1 5.1 4.6 5.3 4.1 5.0 4.1 4.5 4.2 4.7 4.0 4.7 4.4 4.3 4.2 4.2
200 3.7 4.8 3.9 4.6 3.2 4.9 2.9 4.3 2.8 3.9 2.6 3.8 2.6 3.6 2.7 3.5 2.5 3.2
300 0.3 0.4 0.3 0.6 0.3 0.5 0.3 0.4 0.3 0.3 0.2 0.3 0.2 0.3 0.2 0.2 0.2 0.3

Gray shading indicates the most frequently prescribed doses.

LT4, levothyroxine